Correspondence to Dr Masaharu Akao, Department of Cardiovascular Medicine, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan; akao{at}kuhp.kyoto-u.ac.jp Objective The clinical ...

Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...

Background There is substantial interest in the cardiovascular effects of e-cigarette use, highlighting the need to update ...

Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, ...

St George's Hospital Medical School, Histopathology Department, London, UK Professor M J Davies, St George's Hospital Medical School, Histopathology Department, Cranmer Terrace, London SW17 0RE, UK If ...

Background Patients with cryptogenic stroke or embolic stroke of undetermined source (ESUS) face a high risk of recurrent ischaemic stroke, but the optimal antithrombotic strategy remains unclear.

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Background Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier ...

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and systemic embolism after LVT, and many aspects of its management still exist in a ...